Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Colorectal Neoplasms 2Weight Loss 1Sleep Initiation and Maintenance Disorders 1Protein Deficiency 1Prostatic Neoplasms 1Prolactinoma 1Neoplastic Cells, Circulating 1Neoplasms 1Multiple Myeloma 1Melanoma 1Malnutrition 1Kidney Neoplasms 1Iron Deficiencies 1Hemostasis 1Delirium 1Carcinoma, Renal Cell 1Anemia 1

Interventions

suvorexant 2zopiclone 1ramelteon 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Interviews as Topic 1Eszopiclone 1Esketamine 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Sleep Initiation and Maintenance Disorders × Standard of Care × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡